4//SEC Filing
Greenberg Arthur 4
Accession 0001181431-12-041525
CIK 0001133416other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 3:23 PM ET
Size
5.1 KB
Accession
0001181431-12-041525
Insider Transaction Report
Form 4
Greenberg Arthur
Director
Transactions
- Purchase
Common Stock
2012-07-18$1.84/sh+5,000$9,200→ 94,667 total
Footnotes (1)
- [F1]The reporting person in a Form 4 filed on April 18, 2012, voluntarily reported a purchase of the issuer's common stock on April 17, 2012, that was a small acquisition within the meaning of Rule 16a-6 under the Exchange Act that qualified for deferred reporting on Form 5. Had the reporting person elected deferred reporting under Rule 16a-6 for the April 17, 2012 purchase, such purchase when aggregated with the purschase reported herein would have triggered a Form 4 report pursuant to Rule 16a-6(a)(1), but insofar as it has been previously reported, the prior purchase, to avoid confusion, is not included in this report.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeother
Related Parties
1- filerCIK 0001456615
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 3:23 PM ET
- Size
- 5.1 KB